Celiac Disease Clinical Trials

37 recruiting

Celiac Disease Trials at a Glance

41 actively recruiting trials for celiac disease are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Boston, Tampere, and Rochester. Lead sponsors running celiac disease studies include Boston Children's Hospital, Hospital Mutua de Terrassa, and Massachusetts General Hospital.

Browse celiac disease trials by phase

Treatments under study

About Celiac Disease Clinical Trials

Looking for clinical trials for Celiac Disease? There are currently 37 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Celiac Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Celiac Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 41 trials

Recruiting

Liver Steatosis in Pediatric CD Patients

Non-Alcoholic Fatty Liver DiseaseCeliac Disease in Children
University of Palermo91 enrolled2 locationsNCT06206616
Recruiting

Histomolecular Profiling in Small-Bowel Diseases

Celiac Disease
Tampere University Hospital300 enrolled3 locationsNCT07556328
Recruiting
Not Applicable

Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease

Celiac DiseaseAutoimmune DiseasesGluten Sensitivity
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud51 enrolled1 locationNCT07362654
Recruiting
Not Applicable

Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients

Dentin HypersensitivityCeliac DiseaseTooth Demineralization
University of Pavia40 enrolled1 locationNCT07069127
Recruiting
Phase 2

Study of DONQ52 in Active Celiac Disease

Celiac Disease
Chugai Pharmaceutical92 enrolled38 locationsNCT07239336
Recruiting
Phase 1

A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Celiac Disease
Nielsen Fernandez-Becker20 enrolled1 locationNCT07377565
Recruiting
Not Applicable

Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response?

Celiac Disease
Oslo University Hospital30 enrolled2 locationsNCT07039773
Recruiting

Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

Celiac Disease
Massachusetts General Hospital500 enrolled2 locationsNCT02061306
Recruiting
Not Applicable

GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)

Celiac Disease in ChildrenNutrition Disorder, Child
Boston Children's Hospital120 enrolled1 locationNCT06356220
Recruiting
Phase 2

Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease

Celiac Disease
Dr. Falk Pharma GmbH356 enrolled1 locationNCT07298343
Recruiting

Development of New Diagnostic Tools in Capsule Endoscopy

TumorCeliac DiseaseCrohn Disease+2 more
Assistance Publique - Hôpitaux de Paris10,000 enrolled1 locationNCT06152289
Recruiting

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

Celiac DiseaseType 1 Diabetes
Sanford Health33,000 enrolled4 locationsNCT04477928
Recruiting
Not Applicable

Tissue Destruction and Healing in Celiac Disease

Celiac Disease
University of Chicago220 enrolled3 locationsNCT05680012
Recruiting
Phase 2

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Celiac Disease
Teva Branded Pharmaceutical Products R&D LLC48 enrolled21 locationsNCT06807463
Recruiting

AI System for Detection and Characterization of Chronic Enteropathies

Celiac DiseaseSmall Bowel Mucosal Atrophy or LesionsNon-celiac Enteropathies
Istituti Clinici Scientifici Maugeri SpA380 enrolled1 locationNCT07387185
Recruiting
Phase 1

A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

HealthyCeliac Disease
Nielsen Fernandez-Becker18 enrolled1 locationNCT07063823
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+14 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting
Early Phase 1

VTP-1000 in Adults With Celiac Disease

Celiac Disease
Barinthus Biotherapeutics45 enrolled16 locationsNCT06310291
Recruiting

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

Celiac DiseaseMultiple SclerosisAnkylosing Spondylitis+6 more
TScan Therapeutics, Inc.300 enrolled12 locationsNCT06587828
Recruiting
Phase 2

Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease

Celiac Disease
Forte Biosciences, Inc.100 enrolled1 locationNCT06982963